Jeroen van de Pol

103 4 Cost-utility and cost-effectiveness analysis of a clinical medication review Acknowledgements The authors thank all patients, GPs, pharmacists andmembers of Service Apotheek for their participation and support in this study. We also thank the pharmacy students Merve Sivridas, Pawan Rauf, Timo Vogelzang, Sara Cherkaoui, Kim van der Heijden, Zahra Jawad, Manon van Hunnik, Madelon Groenhuis and Milad Rahigh for their help in the data collection. We thank the members of our Scientific Advisory Board for their input regarding the design of the study protocol. This study received unconditional grants from the Royal Dutch Pharmacists Association (‘Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie’, KNMP) and from Service Apotheek as part of the PhD project of S.V. The funders of the study had no role in the design, data management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. Patients received no fee for their participation. Pharmacists received standard reimbursement for the clinical medication reviews from the health insurance companies and a small administrative fee for mailings of questionnaires. Competing interests There are no competing interests to declare. Contributors S.V. conceptualized and designed the study, performed the data collection and data extraction, carried out analyses and interpretation of data, drafted the initial manuscript, and approved the final manuscript as submitted. J.P. conceptualized and designed the study, carried out analyses and interpretation of data, drafted the initial manuscript, and approved the final manuscript as submitted. A.H. conceptualized and designed the study, carried out analyses and interpretation of data, critically reviewed the initial manuscript, and approved the final manuscript as submitted. H.F.K. participated in study design and critically reviewed the manuscript and approved the final manuscript as submitted. J.B. participated in study design and critically reviewed the manuscript and approved the final manuscript as submitted. J.G. participated in study design and critically reviewed the manuscript and approved the final manuscript as submitted. M.L.B. conceptualized and designed the study, carried out interpretation of data, critically reviewed the initial manuscript, approved the final manuscript as submitted and is the principal investigator of this study.